Authors:
Velegraki, A
Kiosses, VG
Kansouzidou, A
Smilakou, S
Mitroussia-Ziouva, A
Legakis, NJ
Citation: A. Velegraki et al., Prospective use of RFLP analysis on amplified Cryptococcus neoformans URA5gene sequences for rapid identification of varieties and serotypes in clinical samples, MED MYCOL, 39(5), 2001, pp. 409-417
Authors:
Kanellopoulou, M
Stamos, G
Petinnelli, I
Savala, M
Tzimogianni, A
Legakis, NJ
Foustoukou, M
Papafragas, E
Velegraki, A
Citation: M. Kanellopoulou et al., Subtyping and antifungal susceptibilities of Candida spp. in the intensivecare unit of a Greek general hospital, INT J ANT A, 18(2), 2001, pp. 179-183
Authors:
Nicolatou-Galitis, O
Dardoufas, K
Markoulatos, P
Sotiropoulou-Lontou, A
Kyprianou, K
Kolitsi, G
Pissakas, G
Skarleas, C
Kouloulias, V
Papanicolaou, V
Legakis, NJ
Velegraki, A
Citation: O. Nicolatou-galitis et al., Oral pseudomembranous candidiasis, herpes simplex virus-1 infection, and oral mucositis in head and neck cancer patients receiving radiotherapy and granulocyte-macrophage colony-stimulating factor (GM-CSF) mouthwash, J ORAL PATH, 30(8), 2001, pp. 471-480
Authors:
Kambouris, ME
Reichard, U
Legakis, NJ
Velegraki, A
Citation: Me. Kambouris et al., Sequences from the aspergillopepsin PEP gene of Aspergillus fumigatus: evidence on their use in selective PCR identification of Aspergillus species in infected clinical samples, FEMS IM MED, 25(3), 1999, pp. 255-264
Authors:
Velegraki, A
Kambouris, ME
Skiniotis, G
Savala, M
Mitroussia-Ziouva, A
Legakis, NJ
Citation: A. Velegraki et al., Identification of medically significant fungal genera by polymerase chain reaction followed by restriction enzyme analysis, FEMS IM MED, 23(4), 1999, pp. 303-312
Authors:
Velegraki, A
Nicolatou, O
Theodoridou, M
Mostrou, G
Legakis, NJ
Citation: A. Velegraki et al., Paediatric AIDS - related linear gingival erythema: a form of erythematouscandidiasis?, J ORAL PATH, 28(4), 1999, pp. 178-182
Authors:
Nicolatou, O
Theodoridou, M
Mostrou, G
Velegraki, A
Legakis, NJ
Citation: O. Nicolatou et al., Oral lesions in children with perinatally acquired human immunodeficiency virus infection, J ORAL PATH, 28(2), 1999, pp. 49-53